Its Oxymovil® is a mobile oxygen generation system designed to adapt to various production scenarios, whether in land-based facilities or at sea via barges.
Oxzo
Chilean company Oxzo, specialized in technological solutions for oxygenation and ozone applications in the aquaculture sector, has received a $25 million investment led by S2G Investments.
Oxymar and Oxymovil, developed by Oxzo, are automated systems for producing oxygen, air, and ozone for the aquaculture industry—both at sea and on land—that enhance productivity, animal welfare, and environmental sustainability.
According to the Chilean company, these solutions increase biomass by 5% to 10%, reduce costs by up to 5%, and lower fish mortality by more than 24%. Oxzo also works with three of Norway’s leading salmon producers to address the sector’s main health challenge—the proliferation of sea lice.
In contrast, and due to new regulations, these systems in Canada offer a more sustainable alternative to land-based grow-out facilities or closed-containment systems.
"We believe Oxzo's solutions are becoming essential for the industry to operate efficiently and sustainably, and we are delighted to partner with Oxzo's management team, which combines deep technical expertise with a clear vision for transforming global aquaculture," said Larsen Mettler, Managing Director of S2G’s Oceans Investment Team.
Additionally, Chairman of Fiordo Austral and Oxzo, Rafael Ariztia, indicated: "We are proud to welcome S2G as an investment partner. Their participation aligns perfectly with Oxzo's strategy to grow in international markets and represents a great opportunity, granting access to highly qualified teams, top-level information, and global networks."
Thanks to its Oceans strategy launched in 2020, S2G became one of the world’s first investment teams dedicated exclusively to the ocean sector. Over the past five years, S2G has invested in 18 portfolio companies.
